TRVI Stock-Based Compensation
Trevi Therapeutics Inc · Stock-Based Compensation
TRVI Stock-Based Compensation
Latest reported$8.06Mperiod ending
TRVI Stock-Based Comp ($142.00 → $8.06M)
Annual stock-based compensation
High-resolution chart · PNG
TRVI stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,185,000 | |
| 3,588,000 | |
| 2,247,000 | |
| 2,327,000 | |
| 2,543,000 | |
| 2,417,000 | |
| 1,127,000 | |
| 496,000 | |
| 205,000 | |
| 142 |